Organon & Co



Ebit تغيير تاريخ
Adcock Ingram Holdings ZAR 541.46M 52.57M 2023-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Celltrion KRW 242.47B 93.05B 2025-06
Cspc Pharmaceutical CNY 1.51B 748.2M 2025-03
Dianthus Therapeutics USD -31916000 2.02M 2024-12
Divis Laboratories Ltd 6.17B 2.48B 2025-06
Gilead Sciences USD 2.7B 189M 2025-06
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Kangmei Pharma CNY -3262057.35 15.91M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 123.33M 85.87M 2024-12
Malin Corporation EUR -2200000 800K 2023-06
Medical Developments International AUD -12124000 3.97M 2023-06
Merck USD 6.36B 149M 2025-06
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Novartis USD 4.86B 286M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Organon & Co USD 360M 135M 2025-06
Pharma Mar EUR 24.15M 27.24M 2025-06
Qiagen NV USD 134.43M 9.77M 2025-06
Sartorius EUR 161.8M 1.8M 2025-06
Sino Biopharmaceutical CNY 3.42B 453.21M 2023-06
Tilray USD -42218000 5.65M 2024-11


Organon & Co - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.